Integration of Cryobiopsies for ILD Diagnoses- Experience Based on 250 Biopsy Procedures.
NCT ID: NCT05311345
Last Updated: 2022-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
250 participants
OBSERVATIONAL
2015-11-06
2020-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cryobiopsy vs. VATS in Diagnosis of Interstitial Lung Diseases
NCT01714518
Interstitial Lung Disease (ILD). Diagnostic Yield of Surgical Lung Biopsy Versus Cryobiopsy in the Same Surgical Stage.
NCT03596528
Prospective, Randomised Multicenter Study Comparing the Efficacy of Transbronchial Forceps Biopsy With Cryobiopsy to Diagnose Interstitial Lung Disease.
NCT01894113
Diagnostic Yield of Transbronchial Cryobiopsy in Diagnosis of Interstitial Lung Diseases
NCT02235779
Study Comparing Two Different Methods of Cryobiopsy in the Interstitial Lung Diseases
NCT03727568
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* suspected of Interstitial lung Disease
* cryobiopsies performed.
Exclusion Criteria
* DLCO below 35%
* Body Mass Index (BMI) above 35
* pulmonary hypertension with a tricuspidal gradient above 40 mmHg
* other cardiac or other comorbidities that would increase the risk of complications
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aarhus University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sissel Kronborg-White
MD, principal investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Cryobiopsy 250
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.